drugset / Trial / NCT07455006
Safety and Efficacy Study of QL0911 to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate efficacy and of safety QL0911 in the treatment of thrombocytopenia in pediatric patients with previously treated chronic ITP.
Timeline
- Start
- 2026-04-20
- Primary completion
- 2027-12-10
- Completion
- 2028-03-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | QL0911 | Protein / enzyme biologic | — | Subcutaneous |